• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK INC BAKRI TAMPONADE BALLOON CATHETER; OQY INTRAUTERINE BALLOON

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK INC BAKRI TAMPONADE BALLOON CATHETER; OQY INTRAUTERINE BALLOON Back to Search Results
Model Number G30673
Device Problem Material Rupture (1546)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/20/2022
Event Type  malfunction  
Manufacturer Narrative
Blank fields on this form indicate the information is unknown or unavailable.Device available for evaluation = unsure if device is available for return.Occupation = non-healthcare professional - unknown.Unsure if device will be returned.This report includes information known at this time.A follow-up report will be submitted should additional relevant information become available.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Event Description
It was reported that the balloon of a bakri tamponade balloon catheter ruptured.The postpartum patient was sent to the delivery room due to poor contraction of the lower uterine segment (uterine atony), and the [device] was used in the delivery room.Compression of the lower uterine segment [was used] to stop the bleeding (the capacity of the intrauterine balloon is 500ml) when 250ml of 0.9% sodium chloride injection is injected, the intrauterine balloon ruptures.The procedure was completed using a new device.A section of the device did not remain inside the patient¿s body.The patient did not require any additional intervention due to this occurrence.The patient did not experience any adverse effects due to this occurrence.Additional information regarding event details, patient anatomy and outcome has been requested but is not available at this time.
 
Manufacturer Narrative
Blank fields on this form indicate the information is unknown or unavailable.B5: additional information received 02jun2022.D9: device available for evaluation = yes.H3: device evaluated by manufacturer = device evaluation anticipated, but not yet begun.This report includes information known at this time.A follow-up report will be submitted should additional relevant information become available.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Event Description
Additional information received 02jun2022: there was 500ml blood loss prior to device deployment and 200ml blood loss after attempted deployment (total ebl 700ml).It was reported that the device was not handled by or in the proximity of any metal tools that may have damaged the balloon.The device is available for return and was sent on 14jun2022.
 
Manufacturer Narrative
Blank fields on this form indicate the information is unknown, unchanged, or unavailable.Event summary it was reported that the balloon of a bakri tamponade balloon catheter ruptured.The postpartum patient was sent to the delivery room due to poor contraction of the lower uterine segment (uterine atony), and the [device] was used in the delivery room.Compression of the lower uterine segment [was used] to stop the bleeding (the capacity of the intrauterine balloon is 500ml) when 250ml of 0.9% sodium chloride injection is injected, the intrauterine balloon ruptures.There was 500ml blood loss prior to device deployment and 200ml blood loss after attempted deployment (total ebl 700ml).It was reported that the device was not handled by or in the proximity of any metal tools that may have damaged the balloon.The procedure was completed using a new device.A section of the device did not remain inside the patient¿s body.The patient did not require any additional intervention due to this occurrence.The patient did not experience any adverse effects due to this occurrence.Investigation ¿ evaluation a visual inspection of the returned device was conducted.A document-based investigation was also performed including a review of complaint history, device history record (dhr), the instructions for use, and quality control data.The complaint device was returned for evaluation without packaging or labeling.Visual examination confirmed that the balloon material was torn in a "v" shape.A review of the device history record (dhr) found no non-conformances related to the reported failure mode.Because there are no related non-conformances, adequate inspection activities have been established, there is objective evidence that the dhr was fully executed, and no other related complaints from the lot have been received from the field, it was concluded that there is no evidence that nonconforming product exists in house or in field.A review of complaint history records shows no other complaints associated with the complaint device lot.The instructions for use (ifu), provides the following information to the user related to the reported failure mode: how supplied: "upon removal from the package, inspect the product to ensure no damage has occurred." the most probable cause of the reported event could not be determined from the available information.Per the quality engineering risk assessment, no further action is warranted.Cook medical will continue to monitor this device via the complaints database for similar complaints.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Event Description
No additional information regarding the patient and/or event has been received since the previous medwatch report was sent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BAKRI TAMPONADE BALLOON CATHETER
Type of Device
OQY INTRAUTERINE BALLOON
Manufacturer (Section D)
COOK INC
750 daniels way
bloomington IN 47404
Manufacturer (Section G)
COOK INC
750 daniels way
bloomington IN 47404
Manufacturer Contact
jason crouch
750 daniels way
bloomington, IN 47404
8128294891
MDR Report Key14569482
MDR Text Key300801676
Report Number1820334-2022-00987
Device Sequence Number1
Product Code OQY
UDI-Device Identifier10827002306735
UDI-Public(01)10827002306735(17)240110(10)13677329
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K170622
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 07/18/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/10/2024
Device Model NumberG30673
Device Catalogue NumberJ-SOS-100500
Device Lot Number13677329
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 05/30/2022
Initial Date FDA Received06/01/2022
Supplement Dates Manufacturer Received06/02/2022
07/07/2022
Supplement Dates FDA Received06/22/2022
07/18/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/10/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age26 YR
Patient SexFemale
-
-